Human PI3/cementoin/ESI ORF/cDNA clone-Lentivirus plasmid (NM_002638)

Cat. No.: pGMLP004215
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human PI3/cementoin/ESI Lentiviral expression plasmid for PI3 lentivirus packaging, PI3 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to Elafin/Skalp/PI3/PI3/cementoin products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $450
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP004215
Gene Name PI3
Accession Number NM_002638
Gene ID 5266
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 354 bp
Gene Alias cementoin,ESI,SKALP,WAP3,WFDC14
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGAGGGCCAGCAGCTTCTTGATCGTGGTGGTGTTCCTCATCGCTGGGACGCTGGTTCTAGAGGCAGCTGTCACGGGAGTTCCTGTTAAAGGTCAAGACACTGTCAAAGGCCGTGTTCCATTCAATGGACAAGATCCCGTTAAAGGACAAGTTTCAGTTAAAGGTCAAGATAAAGTCAAAGCGCAAGAGCCAGTCAAAGGTCCAGTCTCCACTAAGCCTGGCTCCTGCCCCATTATCTTGATCCGGTGCGCCATGTTGAATCCCCCTAACCGCTGCTTGAAAGATACTGACTGCCCAGGAATCAAGAAGTGCTGTGAAGGCTCTTGCGGGATGGCCTGTTTCGTTCCCCAGTGA
ORF Protein Sequence MRASSFLIVVVFLIAGTLVLEAAVTGVPVKGQDTVKGRVPFNGQDPVKGQVSVKGQDKVKAQEPVKGPVSTKPGSCPIILIRCAMLNPPNRCLKDTDCPGIKKCCEGSCGMACFVPQ

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-SE0406-Ab Anti-ELAF/ PI3/ ESI functional antibody
    Target Antigen GM-Tg-g-SE0406-Ag PI3 protein
    ORF Viral Vector pGMLP004215 Human PI3 Lentivirus plasmid
    ORF Viral Vector pGMAAV000494 Human PI3 Adeno-associate virus(AAV) plasmid
    ORF Viral Vector vGMLP004215 Human PI3 Lentivirus particle
    ORF Viral Vector vGMAAV000494 Human PI3 Adeno-associate virus(AAV) particle


    Target information

    Target ID GM-SE0406
    Target Name Elafin/Skalp/PI3
    Gene Group Identifier
    （Target Gene ID in Homo species)         		5266
    Gene ID 100056125 (Equus caballus), 101090932 (Felis catus), 477241 (Canis lupus familiaris), 5266 (Homo sapiens)
    574237 (Macaca mulatta)
    Gene Symbols & Synonyms PI3,SKALP,trappin-2,ESI,WAP3,WFDC14,cementoin,TRAPPIN-2
    Target Alternative Names Elafin, Skalp, PI3,Elafin,Elastase-specific inhibitor (ESI), Peptidase inhibitor 3 (PI-3), Protease inhibitor WAP3, Skin-derived antileukoproteinase (SKALP), WAP four-disulfide core domain protein 14,ESI,WAP3,SKALP,WFDC14,cementoin
    Uniprot Accession P19957
    Additional SwissProt Accessions: P19957
    Uniprot Entry Name
    Protein Sub-location Secreted Protein/Potential Cytokines
    Category
    Disease Ovary Cancer
    Disease from KEGG
    Gene Ensembl ENSECAG00000014295, ENSCAFG00845014356, ENSG00000124102, ENSMMUG00000063099
    Target Classification Pathway


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.